Celltrion News and Activities
Presence
Celltrion is a biotechnology company that develops, makes, and sells biopharmaceutical medicines. Its main products include biosimilars and specialty drugs for hospitals, healthcare providers, and patients in global pharmaceutical markets.
Celltrion products and services overview:
- Biosimilar medicines
- Biologic drugs
- Autoimmune treatments
- Cancer treatments
- Contract manufacturing
Revenue: ~$3 billion
Employees: 3,100
Headquarters: Incheon, Korea, Republic of
Celltrion is one of the...
Celltrion is a company listed under the stock ticker 068270 (KR).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Celltrion
- Woo-Sung Ki, Chief Executive Officer
- Jeong Jin Seo, Chairman of the Board
- Wonk yung Choi, Independent Director
Create your alert
to follow the executive moves at Celltrion.
Biotechnology
Celltrion has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
- RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
- Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
Popular contacts in Biotechnology
News
Press releases by Celltrion
Social media about Celltrion
- Celltrion on Wikipedia, Google News & Yahoo Finance
- Celltrion on LinkedIn, X (Twitter) & YouTube
